Passiflora tripartita (Passifloraceae) Banana Passionfruit, Curuba, Tumbo, Poro Poro
Passiflora tripartita is a woody Andean climber cultivated for its elongated, aromatic fruit and used in traditional medicine as a sedative and anxiolytic. The species is best known in the pharmacological literature through its variety mollissima, which was long confused with Passiflora tarminiana (the subject of the preceding monograph), but P. tripartita sensu stricto is a distinct taxon with its own chemical and biological profile. Modern research has characterized the fruit as a rich source of flavonoid C-glycosides with antioxidant capacity, demonstrated anxiolytic effects of leaf extracts in mice, and identified anti-inflammatory activity in pericarp extracts. The name Passiflora tripartita (Juss.) Poir. is currently accepted, with Tacsonia tripartita as the basionym.
1. Taxonomic Insights
Species: Passiflora tripartita (Juss.) Poir.
Family: Passifloraceae (passionflower family)
Genus: Passiflora
Basionym: Tacsonia tripartita Juss., Annales du Muséum National d'Histoire Naturelle 6: 395, t. 60 (1805)
Synonyms: Tacsonia psilantha Sodiro; Passiflora psilantha (Sodiro) Killip
Nomenclatural note: The species was described by Jussieu as Tacsonia tripartita in 1805 and transferred to Passiflora by Poiret in 1811 . Two varieties are recognized: var. tripartita and var. mollissima (Kunth) Holm-Niels. & P.M. Jørg. The latter is the taxon most frequently encountered in ethnobotanical and pharmacological studies, and it appears in the literature under the synonym Passiflora mollissima (Kunth) L.H. Bailey . Researchers should note that pre-2001 literature referring to "banana passionfruit" or P. mollissima may refer to either P. tripartita var. mollissima or P. tarminiana, which was segregated as a distinct species by Coppens and Barney in 2001.
Botanical Description
No detailed botanical description was available in the search results. The species is a woody climber of the Andean region, with three-lobed leaves and elongated, banana-shaped fruit. It is native to the Andean forests of Venezuela and Bolivia, growing between 1,500 and 3,600 metres above sea level, and is cultivated in home gardens and markets across the Andean region .
Distribution: Native to the Andes, from Venezuela to Bolivia. Cultivated and naturalized in other tropical and subtropical regions .
Etymology
The specific epithet tripartita refers to the three-parted leaves. Vernacular names include curuba (Colombia), tumbo (Peru, Chile), and poro poro (Peru) .
2. Common Names
Scientific Name: Passiflora tripartita | English: Banana Passionfruit | Spanish: Curuba, Tumbo, Poro Poro | Trade name: Banana Passionfruit
3. Related Herbs from the Passifloraceae Family
Passiflora tripartita belongs to the Passifloraceae, the family of passionflowers. It is most closely related to Passiflora tarminiana, with which it was long confused, and to other Andean species in subgenus Tacsonia such as Passiflora mixta. The family is characterized by C-glycosyl flavonoids, which are particularly abundant in the fruit of P. tripartita .
4. Medicinal Uses: Summary of Primary and Secondary Actions
Primary Actions (Experimental):
Anxiolytic: An ethanolic extract of P. tripartita var. mollissima leaves administered intraperitoneally at 100 and 200 mg/kg significantly decreased anxiety levels in mice in the marble burying test (p<0.05). The 200 mg/kg dose produced greater anxiolytic and antidepressant effects, with a correlation direction similar to diazepam. No deaths were observed at any dose used .
Anti-inflammatory: The hydrophilic extract of mature pericarp, at a dose of 500 mg/kg, reduced paw edema in rats, inhibited leukocyte infiltration, modulated oxidative stress, regulated cytokines including IL-1β, IL-6, and TNF-α in inflammatory exudate, and decreased membrane disruption and leukocyte migration in histopathological skin sections .
Secondary Actions (Review-Level and Ethnobotanical):
Antioxidant (fruit): The pulp showed good antioxidant capacity (12.89 ± 0.02 mg/mL in DPPH assay). The peel presented the highest flavonoid content (56.03 ± 4.34 mg quercetin/100 g dry weight), related to its highest antioxidant power (10.41 ± 0.01 mg/mL in DPPH assay) .
Medicinal uses (ethnobotanical): Several parts of the plant are used to treat renal, pulmonary, and gastric problems; it is also described as a vermicide and used to heal cuts .
Medicinal Parts
Leaves: The subject of the anxiolytic study .
Fruit pericarp: The source of anti-inflammatory and antioxidant extracts .
Fruit pulp: Consumed as food and beverage base .
5. Phytochemistry
5.1 Flavonoid C-Glycosides
The fruit is a rich source of flavonoid C-glycosides. Eighteen C-glycosides and four O-glycoside derivatives were detected in methanolic extracts of peel and juice from Chilean-grown fruit. Several C-glycosides are structurally related to 4'-methoxy-luteolin-8-C-(6''-acetyl)-β-D-glucopyranoside, which was fully elucidated by spectroscopic methods. Schaftoside, vicenin II, orientin, and vitexin were isolated from the fruit extract by high-speed countercurrent chromatography .
5.2 Phenolic Content and Antioxidant Capacity
The peel had the highest flavonoid content (56.03 ± 4.34 mg quercetin/100 g dry weight) and the highest antioxidant power (10.41 ± 0.01 mg/mL in DPPH assay). The pulp showed good antioxidant capacity (12.89 ± 0.02 mg/mL in DPPH assay) .
5.3 Seed and Peel Constituents
A review of fruit residues reported that seeds contain a high amount of polyunsaturated fatty acids, phenolics, and terpenes, and are suggested for use in nanoemulsions and as antimicrobials. Terpenes in the essential oil of the seed have been linked to the treatment of colon cancer. The peel contains pectin, dietary fiber, and antioxidant compounds with potential uses as antioxidant additives, enzymatic substrates, and ingredients in toothpaste, soaps, creams, and animal feed .
6. Mechanisms of Action
6.1 Anxiolytic: Neuropharmacological Modulation
The anxiolytic mechanism was characterized using the Irwin test, which assessed locomotor activity, base of support, wobbly gait, immobility, escape, ease of handling, muscular strength, tight rope, inclined plane, catatonia, nociceptive reflex, and death. The extract had a non-significant depressant effect in 11 of 12 tests, and the direction of correlation between diazepam and the Passiflora extract effect was similar. This suggests a benzodiazepine-like profile without significant non-specific depressant effects at the doses tested .
6.2 Anti-inflammatory: Cytokine Modulation and Leukocyte Inhibition
The hydrophilic pericarp extract reduced paw edema, inhibited leukocyte infiltration, and modulated cytokines (IL-1β, IL-6, TNF-α) in inflammatory exudate. Histopathological analysis of skin biopsies showed decreased membrane disruption and leukocyte migration. The authors attributed these effects to the antioxidant compounds in the extract, which reduce oxidative stress and resolve inflammation .
7. Traditional and Ethnobotanical Uses
7.1 Anxiolytic and Anti-inflammatory (Traditional Use in Peru)
Formulation: Leaf extracts and preparations.
Preparation and Use: Extracts from the leaves of several Passiflora species, including P. tripartita, are traditionally used in Peru and in many countries as anxiolytics and for the treatment of inflammatory problems .
Scientific Validation: Anxiolytic activity has been demonstrated in mice at intraperitoneal doses of 100 and 200 mg/kg . Anti-inflammatory activity has been demonstrated for the pericarp extract at 500 mg/kg in rats . No human clinical trials were identified.
7.2 Renal, Pulmonary, and Gastric Problems; Vermicide; Wound Healing
Formulation: Various parts of the plant.
Preparation and Use: Several parts of the plant are used to cure renal, pulmonary, and gastric problems; it is also used as a vermicide and to heal cuts .
Scientific Validation: These uses are documented in ethnobotanical literature but have not been systematically validated in controlled pharmacological studies.
7.3 Fruit as Food
Formulation: Fresh fruit; beverages, cocktails, jams, ice cream.
Preparation and Use: The fruit is eaten fresh or used to make drinks, cocktails, jams, and ice cream. The peel is soft and edible; the pulp contains spherical seeds covered in an orange, juicy coating with an aromatic, sweet, slightly acidic flavor rich in vitamin C .
Scientific Validation: This is a food use, supported by nutritional and phytochemical characterization .
8. Healing Recipes, Teas, Decoctions, and Practical Applications
No standardized medicinal recipes or decoctions were identified in the accessible literature. The fruit is used in beverages, jams, and desserts as food preparations . The leaf extract used in the anxiolytic study was an ethanolic preparation administered intraperitoneally in mice, not a traditional human preparation .
9. Clinical Significance and Evidence Summary
9.1 Evidence Hierarchy by Activity
Anxiolytic: Moderate preclinical evidence from a single mouse study with dose-response data and a benzodiazepine-like profile. No human trials .
Anti-inflammatory: Moderate preclinical evidence from a rat paw edema model with mechanistic characterization (cytokine modulation, leukocyte inhibition). No human trials .
Antioxidant: Moderate in vitro evidence from DPPH assays and flavonoid quantification in fruit fractions .
Ethnomedicinal uses (renal, pulmonary, gastric, vermicide, wound healing): Ethnobotanical documentation only .
9.2 Safety and Toxicology Data
No deaths were observed at any dose used in the mouse anxiolytic study (100 and 200 mg/kg intraperitoneal) . No systematic toxicological studies or human safety data were identified.
10. Safety and Toxicology
10.1 Toxicity Profile
Acute Toxicity: No mortality at 100 and 200 mg/kg intraperitoneal in mice .
Clinical Safety: No human safety data exist.
10.2 Contraindications and Precautions
Pregnancy and Lactation: No data available. Avoid medicinal use in the absence of safety information.
Known Hypersensitivity: Individuals with known allergy to Passifloraceae family plants should exercise caution.
10.3 Potential Drug Interactions
Theoretical additive effects with sedatives, anxiolytics, and other central nervous system depressants are possible given the demonstrated anxiolytic activity and benzodiazepine-like profile . No clinical interaction studies exist.
11. Quality Control Parameters
No validated marker compounds or pharmacopoeial specifications were identified for P. tripartita. The flavonoid C-glycosides (schaftoside, vicenin II, orientin, vitexin) isolated from the fruit are candidates for standardization of antioxidant or anti-inflammatory preparations . Total flavonoid content and DPPH radical scavenging activity can serve as functional quality parameters.
12. Cultivation and Sustainability
The species is native to the Andean forests of Venezuela and Bolivia, growing between 1,500 and 3,600 metres above sea level. It is cultivated in home gardens and gardens in the Andean region, where it flowers and produces fruit almost year-round . In the Angaraes province of Huancavelica, Peru, P. tripartita var. mollissima is one of the species with greatest cultural importance, with its fruits much appreciated by locals and commercialized in provincial fairs .
13. Cultivar and Varietal Comparison
Two varieties are recognized: var. tripartita and var. mollissima (Kunth) Holm-Niels. & P.M. Jørg. The latter is the taxon most frequently studied and cultivated, and it appears in the literature under the synonym Passiflora mollissima (Kunth) L.H. Bailey . No cultivar-specific pharmacological comparisons were identified.
14. Research Gaps and Future Directions
14.1 Critical Research Gaps
Clinical Trials: No human trials exist for the anxiolytic, anti-inflammatory, or other ethnomedicinal indications.
Mechanistic Studies: The anxiolytic mechanism requires characterization at the receptor level; the anti-inflammatory mechanism has been partially characterized but requires identification of the specific active constituents.
Toxicology: No systematic safety data exist beyond the absence of acute mortality in a single mouse study.
14.2 Future Research Priorities
Anxiolytic Clinical Development: The mouse data with a benzodiazepine-like profile justify further preclinical characterization and, potentially, Phase I clinical evaluation.
Anti-inflammatory Compound Development: The pericarp extract data warrant bioassay-guided isolation to identify the active principles.
15. Commercial Applications
The fruit is commercialized in Andean provincial fairs and is used in beverages, jams, and ice cream . The seeds and peel have potential for agroindustrial and pharmaceutical applications, including nanoemulsions, antimicrobials, and antioxidant additives .
16. Related Plants for Further Study
Passiflora tarminiana: The species with which P. tripartita var. mollissima was long confused; comparative phytochemistry and pharmacology are needed to clarify species-specific effects.
Passiflora mixta and other Andean Passiflora species: Comparative studies of anxiolytic and anti-inflammatory activities within subgenus Tacsonia.
17. Reference Literature
Primary Research
Marín Tello C, Gil Velásquez J, Díaz Espinoza D, Vásquez Kool J. Neuropharmacological and anxiolytic effects of extracts of Passiflora tripartita var. mollissima on mice. Revista. 2024;23(1):111-121. This study demonstrates anxiolytic activity at 100 and 200 mg/kg intraperitoneal with a benzodiazepine-like profile .
Evaluation of Bioactive Compounds, Antioxidant Capacity, and Anti-Inflammatory Effects of Lipophilic and Hydrophilic Extracts of the Pericarp of Passiflora tripartita var. mollissima at Two Stages of Ripening. PMC. 2024. This study demonstrates anti-inflammatory activity of the hydrophilic pericarp extract at 500 mg/kg in rats, with cytokine modulation and leukocyte inhibition .
The Passiflora tripartita (Banana Passion) fruit: a source of bioactive flavonoid C-glycosides isolated by HSCCC and characterized by HPLC–DAD–ESI/MS/MS. Europe PMC. 2013. This study identifies eighteen flavonoid C-glycosides and quantifies antioxidant capacity in peel and pulp .
Ethnobotanical and Review Literature
Poro poro - Arca del Gusto - Slow Food Foundation. 2016. Documents traditional food and medicinal uses (renal, pulmonary, gastric problems, vermicide, wound healing) .
Castañeda R, Gutiérrez H, Chávez G, Villanueva R. Ethnobotany of passion flowers (Passiflora) in the Andean province of Angaraes (Huancavelica, Perú). 2019. Documents cultural importance and commercialization of P. tripartita var. mollissima fruits .
Rojas Romaní D, Calixto-Cotos MR, Suca Apaza F. Aprovechamiento de los residuos del fruto de Passiflora tripartita. 2021. Reviews seed and peel composition and potential applications .
Taxonomic References
Kew Plants of the World Online. Passiflora tripartita var. tripartita. Provides accepted name and synonymy .
GBIF Backbone Taxonomy. Passiflora tripartita (Juss.) Poir. Provides accepted name, synonymy, and common name Banana Poka .
ITIS. Passiflora tripartita var. mollissima (Kunth) Holm-Niels. & P.M. Jørg. Provides taxonomic status and synonymy .
GRIN-Global. Passiflora tripartita var. mollissima. Provides basionym and homotypic synonymy .
18. Disclaimer
Passiflora tripartita has documented traditional uses and moderate preclinical evidence for anxiolytic and anti-inflammatory activities, but controlled human clinical trials are lacking for all indications.
This information is for educational and academic purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
The species has been confused in older literature with Passiflora tarminiana, and studies published before 2001 under the name P. mollissima may refer to either taxon. Interpretation of the evidence base requires attention to the taxonomic identity of the study material.
Pregnant or nursing women should avoid medicinal use due to the absence of safety data.
Theoretical additive effects with sedatives and anxiolytics are possible. Consult a healthcare professional before combining with such medications.
Always consult a qualified healthcare practitioner before using any plant for medicinal purposes.

Comments